Immutrix Therapeutics is a medical tech company founded in 2009 and headquartered in Rapid City, South Dakota. The company specializes in pioneering advanced blood purification to combat inflammation and toxicity with innovative adsorbents and smart hollow fiber membranes.
Immutrix Therapeutics focuses on the development and marketing of a blood cleansing treatment device that effectively removes inflammatory mediators and toxins from the blood using proprietary adsorbents and advanced hollow fiber membranes. Their products target and bind molecules, known as modifiers, through a "dialysis-like" procedure to address a wide array of medical conditions. These modifiers are molecules that lead to undesirable immune or pathological responses, commonly referred to as mediators.
In November 2017, Immutrix Therapeutics received a $200.00K Venture Round investment, although the specific investors were not disclosed. The company operates within the industries of Biotechnology, Health Care, Health and Wellness, and Medical Devices.
